- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02657746
Primary Care Strategies to Reduce High Blood Pressure: A Cluster Randomized Trial in Rural Bangladesh, Pakistan and Sri Lanka (COBRA-BPS)
Control of Blood Pressure and Risk Attenuation-Bangladesh, Pakistan and Sri Lanka (COBRA-BPS)
Background: High blood pressure (BP) is the leading attributable risk for cardiovascular disease (CVD). In rural South Asia, hypertension remains to be a significant public health issue with sub-optimal rates of case finding and management. The goal of the full-scale study is to evaluate the effectiveness and cost-effectiveness of multicomponent primary care strategies on lowering blood pressure among adults with hypertension in rural communities in Bangladesh, Pakistan, and Sri Lanka.
Methods/Design: The mixed-methods, stratified cluster randomized controlled trial
Intervention: The multi-component interventions (MCI) is comprised of all the following five components: 1) home health education (HHE) by government community health workers (CHWs), plus 2) blood pressure (BP) monitoring and stepped-up referral to a trained general practitioner (GP) using a checklist, plus 3) training public and private providers in management of hypertension and using a checklist, plus 4) designating hypertension triage counter and hypertension care coordinators in government clinics, plus 5) a financing model to compensate for additional health services and provide subsides to low income individuals with poorly controlled hypertension.
Usual care: Will comprise existing services in the community without any additional training.
Participants: The trial will be conducted on 2550 individuals aged 40 years or older with hypertension (systolic BP ≥ 140 mm Hg or diastolic BP≥ 90 mm Hg, or on antihypertensive therapy) in 30 rural communities of Bangladesh, Pakistan and Sri Lanka. Out of the 2550 individuals, 420 with poorly controlled BP (Systolic BP≥160 mmHg or Diastolic BP≥100 mmHg) will be selected, 14 from each community, to investigate the effect of MCI on results from ambulatory BP monitoring.
Qualitative component: Stakeholders including policymakers, district managers, and community health workers, GPs, hypertensive individuals and family members in the identified clusters will be surveyed.
Outcome: The primary outcome will be change in systolic BP from baseline to follow-up at 24 months post randomization. The cost effectiveness outcome is the incremental cost of MCI per unit reduction in BP over the two year time period and in terms of incremental cost per CVD DALYs averted.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Main study:
Inclusion Criteria:
- Age≥ 40 years
- Residing in the selected clusters
Hypertension defined either as:
- Persistently elevated BP (systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg) from each set of last 2 of 3 readings from 2 separate days
- maintained on anti-hypertensive medications
- Informed consent
Exclusion Criteria:
- Permanently bed-ridden individuals too ill to commute to the clinic
- Pregnancy, or individuals with advanced medical disease (on dialysis, liver failure, other systemic diseases)
- Individuals that are mentally compromised and unable to give informed consent
Sub-study:
1) fulfill all criteria of main study and, 2) Persistently elevated systolic BP >160 mm Hg or diastolic BP >100 mm Hg from each set of 2 readings from 2 separate days
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: usual care
Usual care comprises existing services for hypertension control in the community without any additional training
|
|
Experimental: multi-component interventions
: The multi-component interventions (MCI) is comprised of all the following five components: 1) home health education (HHE) by government community health workers (CHWs), plus 2) blood pressure (BP) monitoring and stepped-up referral to a trained general practitioner (GP) using a checklist, plus 3) training public and private providers in management of hypertension and using a checklist, plus 4) designating hypertension triage counter and hypertension care coordinators in government clinics, plus 5) a financing model to compensate for additional health services and provide subsides to low income individuals with poorly controlled hypertension.
|
The multi-component interventions (MCI) is comprised of all the following five components: 1) home health education (HHE) by government community health workers (CHWs), plus 2) blood pressure (BP) monitoring and stepped-up referral to a trained general practitioner (GP) using a checklist, plus 3) training public and private providers in management of hypertension and using a checklist, plus 4) designating hypertension triage counter and hypertension care coordinators in government clinics, plus 5) a financing model to compensate for additional health services and provide subsides to low income individuals with poorly controlled hypertension.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blood pressure reading:change in systolic blood pressure (SBP) from baseline to follow-up at 24 months post randomization.
Time Frame: Blood pressure (BP) will measured at baseline and then at 6-month intervals until 24 months after randomization
|
Blood pressure (BP) will measured at baseline and then at 6-month intervals until 24 months after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure reading:Blood Pressure(BP) controlled to target (Systolic BP <140 mm Hg and Diastolic BP <90 mm
Time Frame: at 6-month intervals over 24 months
|
at 6-month intervals over 24 months
|
|
Questionnaire:Composite outcome of death (all cause), or hospital admission due to coronary heart disease (CHD), heart failure, or stroke
Time Frame: 24 months
|
24 months
|
|
Questionnaire and EQ-5D-5L:Incremental cost per quality-adjusted life-year (QALY) gained from baseline to end of follow-up
Time Frame: 24 months
|
24 months
|
|
Morisky Medication Adherence Scale(MMAS):Change in antihypertensive medication adherence (Morisky score)
Time Frame: 24 months
|
24 months
|
|
Height and weight measurements:change in body mass index ( BMI)
Time Frame: 24 months
|
24 months
|
|
questionnaire:change dietary salt intake (urinary excretion)
Time Frame: 24 months
|
24 months
|
|
Questionnaire:change in prevalence of current smokers
Time Frame: 24 months
|
24 months
|
|
Questionnaire:incident diabetes
Time Frame: 24 months
|
24 months
|
|
Lipid panel: change in serum lipid levels
Time Frame: 24 months
|
24 months
|
|
questionnaire: change in INTERHEART cardiovascular disease (CVD) risk score
Time Frame: 24 months
|
24 months
|
|
Questionnaire:incidence of adverse outcomes (medication side effects, sick days absenteeism, low QALY between randomized groups).
Time Frame: 24 months
|
24 months
|
|
Questionnaire and serum creatinine:Change in estimated glomerular filtration rate (eGFR)
Time Frame: 24 months
|
24 months
|
|
Urine albumin:Change in urine albumin
Time Frame: 24 months
|
24 months
|
|
24 hours mean diastolic BP
Time Frame: 24 months
|
Secondary outcome for the sub-study of 420 patients with poorly controlled BP at baseline
|
24 months
|
Daytime SBP/DBP
Time Frame: 24 months
|
secondary outcome for the sub-study of 420 patients with poorly controlled BP at baseline
|
24 months
|
Night time SBP/DBP
Time Frame: 24 months
|
Secondary outcome for the sub-study of 420 patients with poorly controlled BP at baseline
|
24 months
|
Dipping Pattern
Time Frame: 24 months
|
Secondary outcome for the sub-study of 420 patients with poorly controlled BP at baseline
|
24 months
|
24 hour BP variability
Time Frame: 24 months
|
Secondary outcome for the sub-study of 420 patients with poorly controlled BP at baseline
|
24 months
|
Questionnaire and EQ-5D-5L:Incremental cost per mm Hg BP reduction from baseline to end of follow-up at two years post randomization and incremental cost per projected cardiovascular disease ( CVD) disability adjusted life year (DALY) averted
Time Frame: information on healthcare cost will be collected at baseline and 24 months
|
information on healthcare cost will be collected at baseline and 24 months
|
|
incremental cost per mm Hg BP reduction from baseline to end of follow-up at 2 years post-randomization and incremental cost per projected CVD disability-adjusted life year (DALY) averted
Time Frame: 24 months
|
24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Tazeen H Jafar, MD,MPH, Duke-NUS Medical School (Singapore)
Publications and helpful links
General Publications
- Feng L, Jehan I, de Silva HA, Naheed A, Khan AH, Kasturiratne A, Clemens JD, Lim CW, Hughes AD, Chaturvedi N, Jafar TH. Effect of a Multicomponent Intervention on Antihypertensive Medication Intensification in Rural South Asia: Post Hoc Analysis of a Cluster RCT. Am J Hypertens. 2021 Sep 22;34(9):981-988. doi: 10.1093/ajh/hpab072.
- Jafar TH, Gandhi M, de Silva HA, Jehan I, Naheed A, Finkelstein EA, Turner EL, Morisky D, Kasturiratne A, Khan AH, Clemens JD, Ebrahim S, Assam PN, Feng L; COBRA-BPS Study Group. A Community-Based Intervention for Managing Hypertension in Rural South Asia. N Engl J Med. 2020 Feb 20;382(8):717-726. doi: 10.1056/NEJMoa1911965.
- Perera M, de Silva CK, Tavajoh S, Kasturiratne A, Luke NV, Ediriweera DS, Ranasinha CD, Legido-Quigley H, de Silva HA, Jafar TH. Patient perspectives on hypertension management in health system of Sri Lanka: a qualitative study. BMJ Open. 2019 Oct 7;9(10):e031773. doi: 10.1136/bmjopen-2019-031773.
- Gandhi M, Assam PN, Turner EL, Morisky DE, Chan E, Jafar TH; COBRA-BPS Study Group. Statistical analysis plan for the control of blood pressure and risk attenuation-rural Bangladesh, Pakistan, Sri Lanka (COBRA-BPS) trial: a cluster randomized trial for a multicomponent intervention versus usual care in hypertensive patients. Trials. 2018 Nov 29;19(1):658. doi: 10.1186/s13063-018-3022-8.
- Feng L, de Silva HA, Jehan I, Naheed A, Kasturiratne A, Himani G, Hasnat MA, Jafar TH. Regional variation in chronic kidney disease and associated factors in hypertensive individuals in rural South Asia: findings from control of blood pressure and risk attenuation-Bangladesh, Pakistan and Sri Lanka. Nephrol Dial Transplant. 2019 Oct 1;34(10):1723-1730. doi: 10.1093/ndt/gfy184.
- Jafar TH, Gandhi M, Jehan I, Naheed A, de Silva HA, Shahab H, Alam D, Luke N, Wee Lim C; COBRA-BPS Study Group. Determinants of Uncontrolled Hypertension in Rural Communities in South Asia-Bangladesh, Pakistan, and Sri Lanka. Am J Hypertens. 2018 Oct 15;31(11):1205-1214. doi: 10.1093/ajh/hpy071.
- Jafar TH, Jehan I, de Silva HA, Naheed A, Gandhi M, Assam P, Finkelstein EA, Quigley HL, Bilger M, Khan AH, Clemens JD, Ebrahim S, Turner EL; for COBRA-BPS Study Group; Kasturiratne A. Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial. Trials. 2017 Jun 12;18(1):272. doi: 10.1186/s13063-017-2018-0.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MR/N006178/1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Addpharma Inc.Completed
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on multi-component interventions
-
Peking Union Medical CollegeChina-Japan Friendship HospitalNot yet recruitingMultimorbidity | Mental Health Issue | Multi-component Interventions
-
Hamad Medical CorporationPrimary Health Care Corporation, QatarRecruiting
-
Fundación Eduardo AnituaRecruiting
-
Peking Union Medical CollegeChina-Japan Friendship HospitalNot yet recruitingMultimorbidity | Chronic Asthma | Population Medicine
-
University of LiverpoolOswaldo Cruz Foundation; University of Warwick; National Institute for Health... and other collaboratorsActive, not recruitingEncephalitis | Meningitis | Abscess BrainIndia, Brazil, Malawi
-
George Washington UniversityActive, not recruitingPrEP | HIV Risk PerceptionUnited States
-
University of Southern DenmarkActive, not recruitingNeck Pain | Shoulder Pain | Lifestyle
-
University of ValenciaRecruitingPhysical Activity | Music Intervention | Fundamental Motor SkillsSpain
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruiting
-
HBSARecruitingBinge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related HarmsUnited States